Your browser doesn't support javascript.
Optimal Long-Acting Injectable Antipsychotic Management During COVID-19.
MacLaurin, Sarah A; Mulligan, Caitlin; Van Alphen, Manjola Ujkaj; Freudenreich, Oliver.
  • MacLaurin SA; Freedom Trail Clinic, 25 Staniford St, Boston, MA 02114. smaclaurin@northsuffolk.org.
  • Mulligan C; North Suffolk Mental Health Association, Boston, Massachusetts, USA.
  • Van Alphen MU; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Freudenreich O; North Suffolk Mental Health Association, Boston, Massachusetts, USA.
J Clin Psychiatry ; 82(1)2021 01 12.
Article in English | MEDLINE | ID: covidwho-1024694

Full text: Available Collection: International databases Database: MEDLINE Main subject: Schizophrenia / Antipsychotic Agents / Communicable Disease Control / Delayed-Action Preparations / Secondary Prevention / COVID-19 Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Adult / Female / Humans / Male Country/Region as subject: North America Language: English Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Schizophrenia / Antipsychotic Agents / Communicable Disease Control / Delayed-Action Preparations / Secondary Prevention / COVID-19 Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Adult / Female / Humans / Male Country/Region as subject: North America Language: English Year: 2021 Document Type: Article